secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2022-04-08T23:59:59+00:00
Accession:  0001171843-22-002480
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics appoints Robert Harrington as director; Dr. Gage resigns, Henderson becomes Chairman
--------------------------------------------------------------------------------

- Robert A. Harrington, M.D. appointed to Board, term through 2024 annual meeting; also joins Science and Technology Committee.
- Dr. Harrington receives $45,000 annual retainer (pro-rated) and option for 35,000 shares vesting over 3 years.
- L. Patrick Gage, Ph.D. resigns as director; not due to any disagreement with the company.
- John T. Henderson, M.D. appointed as Chairman of the Board following Dr. Gage's resignation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000117184322002480/0001171843-22-002480-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000117184322002480/f8k_040822.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-002480

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer